UNSPSC 51124004: Pirmenol

This classification denotes an antiarrhythmic agent with the molecular formula C22H30N2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) VZ3B6ACV72, chemically known as 2-pyridinemethanol, alpha-(3-(2,6-dimethyl-1-piperidinyl)propyl)-alpha-phenyl-, cis-(+-)- but more generally known as pirmenol, which bears US NIH Compound Identifier 4853. European Medicines Agency schedules Pirmenol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09925MIG.

UNSPSC 51124004 Pirmenol is a Commodity code that classifies advanced cardiovascular medications supplied to state and local emergency medical services, health agencies, and cooperative purchasing alliances. State and local governments procure pirmenol and related antiarrhythmic drugs primarily through emergency medical services departments, public health agencies, and multistate cooperative purchasing programs that aggregate pharmaceutical procurement across member jurisdictions. The work involves supplying regulated pharmaceuticals that meet FDA requirements, cGMP certification, Drug Supply Chain Security Act compliance, and specific storage and expiration standards—typically with delivery windows of ten days or less and warranty periods of twelve months or longer against defects.

Recent activity shows issuing bodies spanning city fire rescue departments, state health and human services commissions, and cooperative purchasing alliances. The City of Tampa's Purchasing Department solicited Advanced Life Support Medications (IFB 26P00188, due April 8, 2026, estimated value $40,000) for Tampa Fire Rescue, requiring four specific medication line items with nine-month minimum expiration dates and firm pricing including freight to Florida; the Texas Health and Human Services Commission issued a Request for Information (RFI HHS0017013, response due April 3, 2026) to explore direct-to-manufacturer prescription programs outside traditional pharmacy benefit manager channels; and the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) posted an RFP (S1070000015802, due March 26, 2026) for generic multi-source pharmaceuticals and OTC products distributed across participating state and local facilities in Minnesota and Oregon through three authorized wholesalers. Geographic activity centers on Florida, Texas, and the upper Midwest (Minnesota and Oregon); vendors typically must maintain relationships with established pharmaceutical wholesalers, carry comprehensive insurance including $5,000,000 commercial general liability, submit product data by NDC code, and accept 3 percent administrative fees on cooperative purchasing contracts.